Načítá se...
Antifibrinolytics for heavy menstrual bleeding
BACKGROUND: Heavy menstrual bleeding (HMB) is an important physical and social problem for women. Oral treatment for HMB includes antifibrinolytic drugs, which are designed to reduce bleeding by inhibiting clot‐dissolving enzymes in the endometrium. Historically, there has been some concern that usi...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2018
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6494516/ https://ncbi.nlm.nih.gov/pubmed/29656433 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD000249.pub2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|